SelfCare info...Selfcare, Inc. Announces Third Quarter Results With Strong Revenue Growth - - - PR Newswire - November 15, 1996 09:57
Article excerpts:
The company showed significant revenues growth of $2.0 million or 114% to
$3.8 million in the quarter ended September 30, 1996 and growth of revenues of
$4.3 million or 89% for the nine months ended September 30, 1996 compared to
the same nine months in 1995.
Selfcare, with facilities in Waltham, Massachusetts, Inverness, Scotland,
Galway, Ireland, and Munich, Germany, is engaged in the development,
manufacture and marketing of self-test diagnostic products for the diabetes,
women's health and infectious disease markets.
In September 1996 the company announced FDA clearance for the company's
proprietary electrochemical blood glucose monitoring system, an advanced
version of which, subject to FDA approval, is to be distributed and marketed
by LifeScan, Inc., a subsidiary of Johnson & Johnson.
Increased demand for the company's pregnancy and ovulation products in the
United States resulted in revenue growth for the quarter of $1.1 million or
175% and revenue growth for the nine months ended September 30, 1996 of
$2.8 million or 182%.
Here's the link:
pcquote.newsalert.com
Steve |
